ReviewCurrent gastroenterology reports2011
Ablative therapies for Barrett's esophagus.
Review in Current gastroenterology reports, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 13 citations in OpenAlex.
- Hybrid argon plasma coagulation in Barrett's esophagus: a systematic review and meta-analysis.Clinical endoscopy · 2023Article
- Multi-band mucosectomy for neoplasia in patients with Barrett's esophagus: in vivo comparison between two different devices.Surgical endoscopy · 2020Article
- Feasibility study of endoscopic thermal coagulation with circumferential laser irradiation for treating esophageal tissue.Lasers in medical science · 2020Article
- Photodynamic therapy in gastroenterology.Journal of gastrointestinal cancer · 2013Review
- Management strategies of Barrett's esophagus.World journal of gastroenterology · 2012Review
- Cryotherapy for the eradication of barrett esophagus or early cancer.Gastroenterology & hepatology · 2012Article
- Cellular origin of Barrett's esophagus: controversy and therapeutic implications.Gastroenterology · 2012Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
Abstract
Barrett's esophagus has gained increased clinical attention because of its association with esophageal adenocarcinoma, a cancer with increasing incidence and poor survival rates. The goals of ablating Barrett's esophagus are to decrease esophageal cancer rates and to improve overall survival and quality of life. Different techniques have been developed and tested for their effectiveness eradicating Barrett's epithelium. This review assesses the literature associated with different ablative techniques. The safety and efficacy of different techniques are discussed. This review concludes with recommendations for the clinician, including specific strategies for patient care decisions for patients with Barrett's esophagus with varying degrees of dysplasia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.